Pierre Lorenzo - 21 Jun 2022 Form 4 Insider Report for Tempest Therapeutics, Inc. (TPST)

Reporting relationship: Corporate Controller
Issuer ticker: TPST
Reported as of: 21 Jun 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 22 Jun 2022, 16:38:14 UTC
Prior SEC filing: 06 Jan 2022
Source filing: View source filing
Reporting owner signature: /s/ Pierre Lorenzo

Key filing fact

Pierre Lorenzo filed Form 4 for Tempest Therapeutics, Inc. (TPST) on 22 Jun 2022.

Key facts

This page summarizes Pierre Lorenzo's Form 4 filing for Tempest Therapeutics, Inc. (TPST).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 22 Jun 2022, 16:38.

Change

Previous filing in this sequence was filed on 06 Jan 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TPST transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +8,477
Change %
Price: $0.000000
Shares after: 8,477
Date: 21 Jun 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 8,477
Exercise price: $2.35
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Vests over four (4) years, with one-fourth (1/4) of the award vesting on the first anniversary of the date of grant and the remainder of the award vesting in equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date.